PORTAGE, Mich., June 25, 2025--Stryker received FDA 510(k) clearance for its Incompass® Total Ankle System, intended for patients with severe arthritis-related ankle joint damage.

Stryker (NYSE:SYK) recently received FDA clearance for its Incompass® Total Ankle System, a significant product innovation that highlights the company's commitment to advancing patient care. Over ...

Stryker received FDA 510(k) clearance for its Incompass® Total Ankle System, intended for patients with severe arthritis-related ankle joint damage.

Additionally, Stryker has received FDA 510 (k) clearance for its OptaBlate basivertebral nerve ablation system, aimed at alleviating chronic back pain.

Amy Stryker biography and filmography.MOVIES Movies Now Playing Near Me All Now Playing Movies New Movies This Week Disney+ Netflix Coming Soon Movies On DVD Weekend Box Office Movie Studios ...

Stryker has appointed Mike Carlin to lead its digital and robotics business. Spencer Stiles, Stryker’s group president of orthopaedics, announced Carlin’s new role Wednesday in a LinkedIn post. Robert ...

There has been a shift in leadership for the Digital, Robotics and Enabling Technologies business at Stryker.

Stryker (NYSE:SYK) announced today that it received FDA 510(k) clearance for its Incompass total ankle system.

Stryker has secured FDA clearance for its Incompass total ankle system to treat patients whose ankle joints have been damaged by severe rheumatoid, post-traumatic or degenerative arthritis. The ...